Skip to main content

Murphy Andrew J's Form 4 filing

Regeneron Pharmaceuticals, Inc. (REGN) · filed Aug 15, 2024

Accession no.
0001968202-24-000119
Filed
Aug 15, 2024
Trade date
Aug 13-14, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 20 non-derivative transactions and 1 derivative transaction. Open-market sales total $7.34M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Murphy Andrew JCIK 0001796226Officer (EVP Research)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 13, 2024Common StockMOption exerciseAcquired+20,000$399.66+$7,993,20068,306Direct
Aug 13, 2024Common StockFTax withholdingDisposed−13,637$1,141.49−$15,566,499.1354,669Direct
Aug 14, 2024Common StockSSaleDisposed−55$1,140.31−$62,717.0554,614Direct
Aug 14, 2024Common StockSSaleDisposed−48$1,142.94−$54,861.1254,566Direct
Aug 14, 2024Common StockSSaleDisposed−79$1,143.28−$90,319.1254,487Direct
Aug 14, 2024Common StockSSaleDisposed−45$1,144.89−$51,520.0554,442Direct
Aug 14, 2024Common StockSSaleDisposed−148$1,145.58F2−$169,545.8454,294Direct
Aug 14, 2024Common StockSSaleDisposed−51$1,146.60−$58,476.654,243Direct
Aug 14, 2024Common StockSSaleDisposed−537$1,148.52F3−$616,755.2453,706Direct
Aug 14, 2024Common StockSSaleDisposed−294$1,149.60F4−$337,982.453,412Direct
Aug 14, 2024Common StockSSaleDisposed−844$1,150.41F5−$970,946.0452,568Direct
Aug 14, 2024Common StockSSaleDisposed−185$1,151.46F6−$213,020.152,383Direct
Aug 14, 2024Common StockSSaleDisposed−197$1,152.36F7−$227,014.9252,186Direct
Aug 14, 2024Common StockSSaleDisposed−987$1,153.74F8−$1,138,741.3851,199Direct
Aug 14, 2024Common StockSSaleDisposed−777$1,154.66F9−$897,170.8250,422Direct
Aug 14, 2024Common StockSSaleDisposed−402$1,155.76F10−$464,615.5250,020Direct
Aug 14, 2024Common StockSSaleDisposed−1,016$1,156.43F11−$1,174,932.8849,004Direct
Aug 14, 2024Common StockSSaleDisposed−178$1,157.41F12−$206,018.9848,826Direct
Aug 14, 2024Common StockSSaleDisposed−189$1,158.78F13−$219,009.4248,637Direct
Aug 14, 2024Common StockSSaleDisposed−331$1,159.69F14−$383,857.3948,306Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 13, 2024Common StockMOption exerciseDisposed−20,000$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents volume-weighted average price of sales of 148 shares of Company stock on August 14, 2024 at prices ranging from $1,145.33 to $1,145.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents volume-weighted average price of sales of 537 shares of Company stock on August 14, 2024 at prices ranging from $1,148.06 to $1,148.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents volume-weighted average price of sales of 294 shares of Company stock on August 14, 2024 at prices ranging from $1,149.13 to $1,149.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents volume-weighted average price of sales of 844 shares of Company stock on August 14, 2024 at prices ranging from $1,150.10 to $1,150.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Represents volume-weighted average price of sales of 185 shares of Company stock on August 14, 2024 at prices ranging from $1,151.09 to $1,151.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Represents volume-weighted average price of sales of 197 shares of Company stock on August 14, 2024 at prices ranging from $1,152.27 to $1,152.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F8

Represents volume-weighted average price of sales of 987 shares of Company stock on August 14, 2024 at prices ranging from $1,153.07 to $1,153.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F9

Represents volume-weighted average price of sales of 777 shares of Company stock on August 14, 2024 at prices ranging from $1,154.05 to $1,154.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F10

Represents volume-weighted average price of sales of 402 shares of Company stock on August 14, 2024 at prices ranging from $1,155.04 to $1,155.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F11

Represents volume-weighted average price of sales of 1,016 shares of Company stock on August 14, 2024 at prices ranging from $1,156.06 to $1,156.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F12

Represents volume-weighted average price of sales of 178 shares of Company stock on August 14, 2024 at prices ranging from $1,157.13 to $1,157.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F13

Represents volume-weighted average price of sales of 189 shares of Company stock on August 14, 2024 at prices ranging from $1,158.53 to $1,158.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F14

Represents volume-weighted average price of sales of 331 shares of Company stock on August 14, 2024 at prices ranging from $1,159.21 to $1,159.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)